It's Thursday, February 27th.

Welcome to Market Foolery.

I'm Chris Hill with me in studio.

It's Bill Parker.

Thanks for being here.

Thanks for having me.

We've got earnings.

We're going to dip into the full mail bag. We've got a couple of innovations in the fast casual industry, but we're going to start with the stock of the day and that is Teladoc

Somewhere Jason Moser is smiling, because shares of Tele Doc are up about 20% after fourth

quarter revenue came in higher than expected.

The loss was smaller than expected and it's hard for all of the enthusiasm around the business of

Tele-Doc it's hard for me to look at this and not think at least a little bit of the

rise that we're seeing today with a telemedicine business is tied to coronavirus?

Possibly. It's hard to ask the market what percent of the

enthusiasm is about the results just reported and what part is about things to do with the headlines,

although the guidance is good and really the company kind of avoided on the call giving any specific

numbers about how coronavirus might affect the business but in a world where more people are staying indoors,

staying at home, looking for medical advice and prescriptions and help, but not wanting to be out in public not wanting to

spend time in a hospital and a doctor's office the Teledoc model becomes that much

more attractive.

I think that's smart of management not to really give specifics on that because just as we want and expect the leaders of the companies that we own shares of to talk about the downside of

coronavirus and say well this is what we think the impact is going to be and we're

...